Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1305 in Left Ventricular Dysfunction
NCT00748982Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2008
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of AZD-1305 in Atrial fibrillation (AFib), sponsored by AstraZeneca. Started Aug 2008; status: completed.
02
Drugs
AZD-1305
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00748982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748982.